Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials
- Written by ACN Newswire
SYDNEY, AUS, May 18, 2018 - (ACN Newswire) - Leading Asia Pacific CRO Novotech commended the Turnbull Government's Federal Budget decision to exclude clinical trials activity from a A$4m cap on cash refunds, or any lifetime cap on refunds.Novotech CEO Dr John Moller said the move reaffirms Australian's lead position in attracting foreign...